logo

Ultragenyx Pharmaceutical Inc (RARE)



Trade RARE now with
  Date
  Headline
12/15/2017 4:58:37 PM Wedbush Is Increasing Ultragenyx Pharmaceutical Inc (RARE) FY18 Estimate To -4.43 From -4.47
12/15/2017 4:58:18 PM Wedbush Is Increasing Ultragenyx Pharmaceutical Inc (RARE) Q4 18 Estimate To -2.10 From -2.12
12/15/2017 4:56:38 PM Wedbush Is Raising Ultragenyx Pharmaceutical Inc (RARE) Q3 18 Estimate To -0.77 From -0.78
12/15/2017 4:56:16 PM Wedbush Is Raising Ultragenyx Pharmaceutical Inc (RARE) Q2 18 Estimate To -2.08 From -2.11
12/15/2017 4:55:59 PM Wedbush Is Lowering Ultragenyx Pharmaceutical Inc (RARE) Q1 18 Estimate To 0.53 From 0.54
12/15/2017 8:32:48 AM Ultragenyx And Kyowa Kirin : Burosumab Gets Positive CHMP Opinion For Treatment Of X-Linked Hypophosphatemia In Children
12/7/2017 10:48:10 PM New Drugs Approved In November
12/5/2017 1:01:38 PM Wedbush Is Cutting Ultragenyx Pharmaceutical Inc (RARE) FY18 Rev. Estimate To 226.6 M From 235.3 M
12/5/2017 1:01:21 PM Wedbush Is Cutting Ultragenyx Pharmaceutical Inc (RARE) Q4 18 Rev. Estimate To 14.0 M From 18.9 M
12/5/2017 1:01:01 PM Wedbush Is Lowering Ultragenyx Pharmaceutical Inc (RARE) Q3 18 Rev. Estimate To 74.5 M From 78.3 M
12/5/2017 1:00:14 PM Wedbush Is Cutting Ultragenyx Pharmaceutical Inc (RARE) FY18 Estimate To -4.47 From -4.32
12/5/2017 12:59:48 PM Wedbush Is Cutting Ultragenyx Pharmaceutical Inc (RARE) Q4 18 Estimate To -2.12 From -2.04
12/5/2017 12:59:28 PM Wedbush Is Lowering Ultragenyx Pharmaceutical Inc (RARE) Q3 18 Estimate To -0.78 From -0.72
12/5/2017 12:59:09 PM Wedbush Is Cutting Ultragenyx Pharmaceutical Inc (RARE) Q2 18 Estimate To -2.11 From -2.10
12/4/2017 7:35:48 AM Ultragenyx, Kyowa Kirin Report Positive 48-Week Data From Adult Phase 3 Study Of Burosumab In X-Linked Hypophosphatemia
11/17/2017 8:21:50 AM Wedbush Is Raising Ultragenyx Pharmaceutical Inc (RARE) 2018 Estimate To -4.32 From -6.93
11/17/2017 8:21:31 AM Wedbush Is Cutting Ultragenyx Pharmaceutical Inc (RARE) 2017 Estimate To -7.49 From -4.55
11/17/2017 8:20:49 AM Wedbush Is Increasing Ultragenyx Pharmaceutical Inc (RARE) 2018 Rev. Estimate To 235.3 M From 111.0 M